NFKB1 and inflammatory bowel disease: In intestinal epithelial cells, AHR activation improves intestinal barrier function by maintaining tight junction proteins (ZO-1, Occludin, and Claudin-1) and alleviates inflammation by inhibiting NF-κB, thereby improving inflammatory bowel disease [48].